A. O. C. Costa

A. O. C. Costa

Auto-generated profile, based on publicly available information

A. O. C. Costa

Universidade Federal da Paraíba, Brasil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2016 in International Journal of TROPICAL DISEASE & Health
Verified
Journal Article
Open access
JSJaniere Sousa
Janiere Sousa
ACAratã Costa
Aratã Costa
MLMaria Luísa Leite
Maria Luísa Leite
FGFelipe GUERRA
Felipe GUERRA
VSViviane Silva
Viviane Silva
ELEdeltrudes De Lima Oliveira Lima
Edeltrudes De Lima Oliveira Lima
A limited number of antifungals and the emergence of resistant strains have hindered the treatment of candidiasis, making the search for new antifungals urgent. Citral is a monoterpene with known pharmacological properties, including antimicrobial action. Aims: Thus the objective of this study was to investigate the possible mechanism of citral’s action against Candida tropicalis isolated from human blood, and the effect of its association with antifungals. Methodology: The minimum inhibitory concentration (MIC), the minimum fungicidal concentration (MFC), the effect of citral on the cell wall (sorbitol assay), and membrane ergosterol binding were evaluated using broth microdilution technique. We also evaluated interference in ergosterol biosynthesis, and the citral-antifungal association effect (checkerboard method). Results: The MIC90 and MFC90 of citral were respectively 512 and 1024 μg / mL. The MIC of citral did not increase when sorbitol or ergosterol was added to the medium, suggesting that citral does not act on the cell wall or by membrane ergosterol binding. However, citral inhibited ergosterol biosynthesis, and the citral-fluconazole combination showed synergistic effects for the ATCC strain. Conclusion: This study contributes to understanding the antifungal mechanism of citral’s action, and to the development of new therapies for candidiasis treatment.

1 January 2023 in Brazilian Journal of Biology
Verified
Journal Article
Open access
PDF file
ACA. O. C. Costa
A. O. C. Costa
RRR. I. A. Rego
R. I. A. Rego
HAH. H. N. Andrade
H. H. N. Andrade
TCT. K. V. L. Costa
T. K. V. L. Costa
Mirian Stiebbe SalvadoriMirian Stiebbe Salvadori
Mirian Stiebbe Salvadori
RCRicardo Castro
Ricardo Castro
Due to the complex nature of pain and the participation of physical, cognitive, psychological and behavioral aspects, pain management has several approaches. The use of medicinal plants in developing countries is quite expressive. Seeking new options for the treatment of emerging or debilitating diseases. Therefore, the present study seeks to elucidate the effects of the monoterpene, citronellal, differentiating its activity by isomers (R)-(+) and (S)-(-) citronellal. The study used several methods to evaluate the effects of citronellal isomers on motor coordination, nociceptive response, and the involvement of opioid, glutamatergic, and transient receptor pathways. The methods included rota-rod, hot-plate, and formalin tests, as well as the use of specific inhibitors and agonists. Data were analyzed using inferential statistics with a 95% confidence level. Both isomers did not significantly affect the motor coordination of the studied animals. The isomer (S)-(-) citronellal showed better results in relation to its structural counterpart, managing to have an antinociceptive effect in the formalin and hot plate tests with a lower concentration (100 mg/kg) and presenting fewer side effects, however, the this study was not able to elucidate the mechanism of action of this isomer despite having activity in studies with substances that act on specific targets such as glutamate and capsaicin, its activity was not reversed with the use of antagonists for pathways related to nociception. While the (R)-(+) citronellal isomer, despite showing total activity only at a concentration of 150 mg/kg, was able to determine its mechanism of action related to the opioid pathway by reversing its activity by the antagonist naloxone, being this is a pathway already correlated with nociception control treatments, however, it is also related to some unwanted side effects. In this way, new studies are sought to elucidate the mechanism related to the isomer (S)-(-) citronellal and a possibility of use in other areas related to the treatment of pain or inflammation.